glp 1 agonist risks Benefits and of GLP-1 Receptor Agonists Outlined glp 1 agonist risks GLP-1

Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial

The diabetes rate among women in India has risen from 11.9% in 1990 to 23.7% in 2022, representing one of the biggest increases among other countries

doi:10.3389/fendo.2024.1309118 24

Fmoc deprotection was achieved with 20% piperidine in DMF (twice for 2 min, room temperature, 300 rpm shaking) and peptide couplings were performed as double or triple couplings (twice for 5 min, 75 C, 300 rpm shaking, except for Arg and His, for which twice for 5 min, 50 C, 300 rpm shaking) consisting of AA/HCTU/DIPEA (ratio, 1:1.25:2.5) in fivefold excess compared to the resin